Binding Activity Classification of Anti-SARS-CoV-2 Molecules using Deep Learning Across Multiple Assays.

Journal: Balkan medical journal
PMID:

Abstract

BACKGROUND: The coronavirus disease-2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), has urgently necessitated effective therapeutic solutions, with a focus on rapidly identifying and classifying potential small-molecule drugs. Given traditional methods’ labor-intensive and time-consuming nature, deep learning has emerged as an essential tool for efficiently processing and extracting insights from complex biological data.

Authors

  • Bilge Eren Yamasan
    Department of Biophysics, Trakya University Faculty of Medicine, Edirne, Türkiye
  • Selcuk Korkmaz
    Department of Biostatistics, Faculty of Medicine, Hacettepe University, Sihhiye, Ankara, Turkey.